Boiler Room: The Official Stock Market Discussion

Arithmetic

Veteran
Supporter
Joined
Mar 6, 2015
Messages
49,588
Reputation
14,552
Daps
263,017
@Arithmetic A SPAC deal like that is not unusual. Tilman owned LCA which is merging with Golden Nugget. He was in control of the entire thing which was known from the beginning and all it told me as an investor was that the deal was quite obviously going to get done since Tilman was working both sides. Some call it shady, call it what you will but the confidence for me to invest was at 100% in part because of that and then you look a few months later and it's up over 100%

As for IPOC the bullish case is solely because the sector is hot and SPACs are hot and Chameth has been on a roll (the man behind SPCE, IPOB, etc. )

You aren't investing in Clover Health, you are investing in the idea that Chameth + the sector will allow it to run...
I'm a historical facts nerd breh don't mind me lol. I'm in IPOC as well. Biden is going to push for lowering the eligibility to 60+ and expanding Medicare Advantage which is another bullish case. Fact Sheet: How Joe Biden Would Help You Get Health Insurance Coverage During the Coronavirus Crisis | Joe Biden for President: Official Campaign Website
 

Kal El

All Star
Joined
May 18, 2012
Messages
2,860
Reputation
440
Daps
11,896
Reppin
USA
@Arithmetic A SPAC deal like that is not unusual. Tilman owned LCA which is merging with Golden Nugget. He was in control of the entire thing which was known from the beginning and all it told me as an investor was that the deal was quite obviously going to get done since Tilman was working both sides. Some call it shady, call it what you will but the confidence for me to invest was at 100% in part because of that and then you look a few months later and it's up over 100%

As for IPOC the bullish case is solely because the sector is hot and SPACs are hot and Chameth has been on a roll (the man behind SPCE, IPOB, etc. )

You aren't investing in Clover Health, you are investing in the idea that Chameth + the sector will allow it to run...
IPOD/IPOE/IPOF are all at the same price or higher than IPOC WITHOUT a target.

I’ve got money parked in all of them with hopes that Chamath finds more appealing target than he did with IPOC.
 

K-Deini

GOAT
Supporter
Joined
Apr 30, 2012
Messages
15,563
Reputation
2,958
Daps
38,464
Strange day today. Was up almost 8% and ended up only 1.7

Need sos to go. Chart looking good. Then I can dump more in pacb
 
Joined
May 1, 2012
Messages
180,055
Reputation
22,596
Daps
588,490
Reppin
49ers..Braves..Celtics
I think this is a good time to reiterate something we touched on a few pages back. The price action on SPACs is more volatile than Tesla. There's usually two waves prior to merger depending on what sector we're looking at.. and you have that ten dollar floor to play with.

Post-merger it's like any other company, it's treated way more harshly. If it's something like SPCE it can 2x 3x. If it's something like DKNG it can 5x 6x.. from the floor..likely more.

But there are others that handle the post-merger terribly and we are seeing that with Hyliion right now which I haven't looked at in a while but it's currently trading at $16. It was trading at $50 prior to the merger.

The EV sector was red hot and that's great for a spec play. HYLN (previously known as SHLL) rode that way but they did not capitalize and people aren't going to stick with a ticker that was a spec play to begin with (and all the DD looked great on paper, they sold themselves well) when you are giving them nothing to go on.. HYLN hasn't done anything to keep investors engaged.

So just be careful out here with these. They are great money makers but do not chase them they will come to you and like any other stock know when it's time to secure PROFITS. We are in here to make money. Some stocks you want to hold for 5-10 years but others...maybe not, secure the bag.
 

FabTrey

Superstar
Joined
Apr 2, 2017
Messages
12,944
Reputation
-1,689
Daps
28,267
This weekend I was doing some DD on IPOC.

When I started I thought IPOC was going to end up being one of my high-conviction stocks, but now I might stay away.

My first big concern is the management team: they might be under investigation. The CEO, Vivek Garipalli, and his partners also own a company that has three hospitals. Apparently, they are accused of embezzling $169 million, and falsifying the books. New Jersey state officials condemned their actions, but haven't yet recommended a criminal investigation. They also have a civil case going.

NJ legislators call for probe of insurance unicorn - MedCity News

Once I read that, I re-read the investor documents with a lot more skepticism.

Now, I don't see anything innovative about the company. The claims about the Clover Assistant, which doctor's use to provide service to patients, just does not sound innovative. They only have 57 thousand members, most of which they probably got through their three hospitals in NJ. From where are they getting Big Data? Medical information is highly protected.

They are overwhelmingly based in NJ. They haven't been able to scale.

I just don't see how they are going to take on the big boys in insurance and health care,which have millions of patients from which to draw data.

They try to position themselves as a tech company, and they use all of the Silicon Valley buzzwords, but if their technology is so advanced, why aren't they planning to sell to all doctors and hospitals? If you can cut doctor's paperwork per patient from 16 minutes down to 5, why aren't you selling your tech?

This might be a decent momentum play, but I don't see a disruptive company.

What am I missing? After all, I am a newb, and I ain't a medical professional.

The management team seems shady. They might leave after the big payday.

I won't be surprised if this acquisition gets cancelled. I can see the shareholders being a bit skeptical.


i felt like there was no need for a DD. This is a pure belief in Chamath hype. a spec stock where i'm more interested day to day price changes rather than the company itself.

but great job on DD. i wouldn't touch going long with a company like this. at least not yet.
 
Last edited:

FabTrey

Superstar
Joined
Apr 2, 2017
Messages
12,944
Reputation
-1,689
Daps
28,267
BFT got all the YouTubers discussing it now. IPOC is still a bit more under the radar in those circles but I can't complain with my $10.60 average. I think some big money will eventually get in

i'll take any kind of hype. hype on youtube helped SHLL alot. i don't think we'll see SHLL like run up before the merger. damn i really blew it with SHLL. got too greedy.

hopefully both BFT and IPOC gets to $20 quick.
 

FabTrey

Superstar
Joined
Apr 2, 2017
Messages
12,944
Reputation
-1,689
Daps
28,267
I bought some shares a while back just for a quick flip. Looking to sell those later this week.

Will still barely be part of triple digit Tesla gang.


when did you buy and why you have an urge to sell? you need to spend money? :jbhmm:
if you are going to sell then i recommend holding at least 1 year, so you pay less taxes. :manny:
 

Serious

Veteran
Supporter
Joined
Apr 30, 2012
Messages
79,926
Reputation
14,208
Daps
190,262
Reppin
1st Round Playoff Exits
This weekend I was doing some DD on IPOC.

When I started I thought IPOC was going to end up being one of my high-conviction stocks, but now I might stay away.

My first big concern is the management team: they might be under investigation. The CEO, Vivek Garipalli, and his partners also own a company that has three hospitals. Apparently, they are accused of embezzling $169 million, and falsifying the books. New Jersey state officials condemned their actions, but haven't yet recommended a criminal investigation. They also have a civil case going.

NJ legislators call for probe of insurance unicorn - MedCity News

Once I read that, I re-read the investor documents with a lot more skepticism.

Now, I don't see anything innovative about the company. The claims about the Clover Assistant, which doctor's use to provide service to patients, just does not sound innovative. They only have 57 thousand members, most of which they probably got through their three hospitals in NJ. From where are they getting Big Data? Medical information is highly protected.

They are overwhelmingly based in NJ. They haven't been able to scale.

I just don't see how they are going to take on the big boys in insurance and health care,which have millions of patients from which to draw data.

They try to position themselves as a tech company, and they use all of the Silicon Valley buzzwords, but if their technology is so advanced, why aren't they planning to sell to all doctors and hospitals? If you can cut doctor's paperwork per patient from 16 minutes down to 5, why aren't you selling your tech?

This might be a decent momentum play, but I don't see a disruptive company.

What am I missing? After all, I am a newb, and I ain't a medical professional.

The management team seems shady. They might leave after the big payday.

I won't be surprised if this acquisition gets cancelled. I can see the shareholders being a bit skeptical.
I came across this a few weeks back and I kinda just shrugged it off. A lot of companies and business owners have "fraud" linked to them. Sometimes there is, sometimes there isn't. I know from personal experience not to look into the accusations too closely.

Service is real and it's ability to scale is there.

That's why I'm watching it's movement going forward closely to track progress. I have an industry insight because I studied this and know what red flags to look for. I always said this is a long term play.
 

Serious

Veteran
Supporter
Joined
Apr 30, 2012
Messages
79,926
Reputation
14,208
Daps
190,262
Reppin
1st Round Playoff Exits
As far as the Clover Assistant the data is fine in house. It can't be sold to other companies and it can't have identifiable information, like someone's personal can't be fully displayed. But if the doctors work for Clover Health then that allows for them store the data.

I work with medical data sets all day myself.

:yeshrug:
 
Top